首页> 外文期刊>Nature reviews. Urology >Kidney cancer: First in vivo study shows optical imaging can distinguish renal cancer from normal tissue
【24h】

Kidney cancer: First in vivo study shows optical imaging can distinguish renal cancer from normal tissue

机译:肾癌:首项体内研究显示光学成像可将肾癌与正常组织区分开

获取原文
获取原文并翻译 | 示例
           

摘要

Optical coherence tomography (OCT) is a high-resolution light-based technique widely used in ophthalmology to image the retina in real time. Researchers in The Netherlands have transferred this technique to the human kidney, and now they report the first in vivo study of OCT for renal tumours in BJU International. Their finding that OCT can accurately differentiate between malignant renal tissue and normal parenchyma suggests that OCT might prove to be a reliable, minimally invasive alternative to biopsy for the diagnosis of kidney cancer. "One of the major reasons that a renal mass biopsy is not included in the standard diagnostic workup is the high number of nondiagnostic biopsy results-about 20% in most contemporary studies," says Kurdo Barwari, lead author of the study.
机译:光学相干断层扫描(OCT)是一种高分辨率的基于光的技术,广泛用于眼科领域以实时成像视网膜。荷兰的研究人员已将该技术转移到人的肾脏,现在,他们在BJU International上报道了首项针对肾肿瘤的OCT体内研究。他们发现OCT可以准确区分恶性肾脏组织和正常实质,这表明OCT可能被证明是活检的可靠,微创替代品,可用于诊断肾癌。该研究的主要作者库尔多·巴瓦里说:“标准诊断检查中不包括肾脏肿块活检的主要原因之一是非诊断性活检结果的数量很高,在大多数当代研究中约为20%。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号